Search

Your search keyword '"Radü EW"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Radü EW" Remove constraint Author: "Radü EW" Topic magnetic resonance imaging Remove constraint Topic: magnetic resonance imaging
18 results on '"Radü EW"'

Search Results

1. Cingulate volume abnormalities in emerging psychosis.

2. Globe restriction in a severely myopic patient visualized through oculodynamic magnetic resonance imaging (od-MRI).

3. Regional gray matter volume abnormalities in the at risk mental state.

4. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.

5. fMRI of the auditory cortex in patients with unilateral carotid artery steno-occlusive disease.

6. Prenatal diagnosis of an infratentorial subdural hemorrhage: case report.

7. Dynamic patterns of USPIO enhancement can be observed in macrophages after ischemic brain damage.

8. Auditory system: functional magnetic resonance imaging.

9. Effect of ethanol on BOLD response to acoustic stimulation: implications for neuropharmacological fMRI.

10. Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: application of an extended blood-brain barrier leakage correction.

11. Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility.

12. [MRI follow-up in multiple sclerosis. A guideline for quality assurance].

13. The MR tomograph as a sound generator: fMRI tool for the investigation of the auditory cortex.

14. Foramen of Monro mass: MRI appearances permit diagnosis of cavernous haemangioma.

15. [Visualization of the normal basilar artery and its branches using magnetic resonance angiography (MRA)].

16. Treatment of multiple sclerosis with 15 +/- deoxyspergualin. Design of a controlled study with close MRI-monitoring.

17. [Multiple sclerosis: correlation between clinically suspected locations and ascertained lesions in MRI].

18. Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

Catalog

Books, media, physical & digital resources